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Abstract 
Objectives  and  Aims: to  compare  guideline  recom-
mendations with daily practice patterns in a German
patient cohort with renal cell carcinoma.
Patients and Methods: 81 patients with t1 oder t2 re-
nal  cell  carcinoma  (RCC)  were  included  in  this
prospective single-center study. all patients were oper-
ated  in  a  single  institution  either  by  open  radical
nephrectomy  (oRn)  or  nephron  sparing  surgery
(nss).  Patients  and  doctors  were  evaluated  using  a
written questionnaire with a follow-up of 12 months.
follow-up intervals, follow-up modalities (e. g. imaging
modalities, laboratory controls of blood and urine) and
the call on psycho-oncological support were evaluated.
Results: the majority of patients (72%) were followed
up by their urologists. follow-up examinations includ-
ed abdominal ultrasound, urine and blood diagnostics,
conventional chest x-rays, computed tomography (Ct)
of  abdomen,  chest  or  head  or  abdominal  Magnetic
Resonance Imaging (MRI). there were no significant
differences  between  patients  operated  by  oRn  or
nss. In total, 12.5% of patients were asking for psy-
cho-oncological support.
Conclusions: In general, patients were followed up ac-
cording to existing guideline recommendations. only a
small proportion of patients asked for psycho-onco-
logical treatment.
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1. IntRoduCtIon
the incidence of renal cell carcinoma (RCC) is esti-
mated to be 46.000 per year in the European union
with an annual increase of 2 - 3% [1, 2]. one third of
patients is dying within 5 years after first diagnosis [3].
Men develop renal cell carcinoma more often with a
1.5 : 1 –ratio compared to women. with a mean age of
65 years at first diagnosis, 25 – 35% of patients pre-
sent with metastatic disease [4]. 
due to improved imaging techniques such as ultra-
sound and Ct-scanners in the developed countries, tu-
mors are nowadays discovered incidentally during rou-
tine  scans.  these  tumors  are  often  asymptomatic,
smaller in size and of lower stage [5, 6].
according to the European association of urolo-
gy (Eau) guidelines on RCC, surgical options for the
primary  tumor  include  radical  nephrectomy,  organ
preserving  partial  nephrectomy  and  laparoscopic
nephr  ectomy [7]. for small and/or peripheral located
tumors an organ preserving approach is recommend-
ed. 
the aim of follow-up after surgical therapy of RCC
is  to  monitor  and  identify  post-operative  complica-
tions,  renal  function,  local  recurrence,  recurrence  in
the  contralateral  kidney  and  development  of  metas-
tases  [7].  surprisingly,  the  Eau  guidelines  on  RCC
state that there is no consensus about the ideal onco-
logical follow-up for patients after surgery for RCC;
neither do they provide a risk stratification for differ-
ent follow-up strategies of patients operated by organ
preserving techniques or radical surgery.
we therefore conducted a prospective study to in-
vestigate how the follow-up of patients with a history
of RCC is performed in daily practice. we hereby fo-
cused  on  patients  who  had  undergone  open  radical
nephrectomy (oRn) or open nephron-sparing surgery
(nss) for t1 and t2 RCC. we investigated follow-up
modalities and frequency and compared it to the exist-
ing guidelines. furthermore we examined if the fol-
low-up modalities were different when performed by a
certified urologist or general practitioner. finally pa-
tient’s preference towards psycho-oncological support
was assessed.
2. PatIEnts and MEtHods
PatIEnts
In this prospective single-center study patients under-
going surgery at our institution for renal cell carcino-
ma stage t1 or t2 were included. all analyses were
conducted  according  to  the  guidelines  of  the  local
Ethical Committees. Between January and december
2005 81 patients (29 female, 52 male) with a mean age
of 63 ﾱ 3 years met the inclusion criteria. 37 patients
(45.7%)  underwent  oRn  and  44  (54.3%)  nss.  Pa-
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tionnaire with a follow-up of 12 months. the follow-
ing parameters were examined: which specialist (urolo-
gist,  nephrologist,  oncologist,  specialist  for  internal
medicine) was performing oncological follow-up, fol-
low-up  intervals,  follow-up  modalities  (e.  g.  imaging
modalities,  laboratory  controls  of  blood  and  urine)
and the call on psycho-oncological support. 
suRGERy
Radical nephrectomy was performed as described be-
fore [8, 9]. Briefly, the kidney was accessed according
to the principles of Robson through a flank incision,
with early control of the renal artery and vein, and
complete extraction of Gerota’s fascia. adrenalectomy
was used only if preoperative screening or intraopera-
tive palpation revealed suspect masses. lymphadenec-
tomy was not used regularly, but only if suspect nodes
were detected during preoperative staging or surgery.
nss was usually done through a flank incision with a
retroperitoneal approach. Clamping was used for com-
plex resections, with smaller peripheral lesion not be-
ing resected under ischaemia [10].
3. REsults
oncological follow-up was performed by urologists in
72% of patients, by the general practitioners in 20%,
by nephrologists in 9%, by oncologists in 5% and by
specialists for internal medicine in 4% of cases (see
fig. 1).
follow-up examinations included abdominal ultra-
sound, urine and blood diagnostics, conventional chest
x-rays, computed tomography (Ct) of abdomen, chest
or  head  or  abdominal  Magnetic  Resonance  Imaging
(MRI). for detailed follow-up modalities see figure 2.
the follow-up modalities were different for urolo-
gists  and  non-urologists.  all  technical  follow-up
modalities were used more often by urologists than by
non-urologists. for all differences see figure 3.
the majority of patients underwent follow-up every
3 months during the first year after surgery. Most pa-
tients were willing to actively participate in oncolgical
follow-up. see figure 4 for detailed information about
follow-up intervals.
In total, 12.5% of patients asked for psycho-onco-
logical support (see figure 5 for details and differences
between oRn and nss). 
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Fig. 1. Medical speciality performing onco-
logical follow-up.
72 Urologist
20 General practitioner
9 Nephrologist
5 Oncologist
4 Specialist for Internal
medicine
Fig. 2. follow-up modalities for oRn and nss.
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Renal cell carcinoma is a frequent and aggressive tu-
mor entity. oncological follow-up is of major concern
as local and contralateral recurrence occurs (1.2% and
1.8% respectively) [11]. Early detection of recurrence
is  of  utmost  importance  as  cytoreductive  surgery  is
the key for successful treatment [12, 13]. surprisingly
there is no consensus on the ideal postoperative sur-
veillance strategy [7]. to assess the risk of either local
or contralateral recurrence several prognostic factors
were  identified  and  scoring  systems  and  algorithms
were developed [14-17]. despite the reliable prediction
of recurrence in a defined cohort of patients (e. g. pa-
tients  treated  at  the  university  of  California  at  los
angeles) these nomograms have not gained wide ac-
ceptance in Germany [18].
to define the ideal follow-up modality it is essential
to know time and localization of recurrence and to
adapt the imaging modalities accordingly. larger au-
topsy studies have shown that even clinically undetect-
ed RCC spreads to lung (2 – 14%), bone (1 – 7.6%)
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Fig. 3. differences in follow-up modalities between urologists and non-urologists.
Fig.4. follow-up intervals after oRn and nss.
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have  to  be  monitored  closely  during  follow  up.  for
small tumors the risk of recurrence seems to be inde-
pendent of radical or organ sparing surgery [12, 19,
22, 23]. therefore the Eau guidelines suggest rather a
risk  stratification  by  histopathological  factors  like
grading, pathological stage and lymph node status than
the type of surgery performed [7]. In low-risk patients
routine Ct scans are not recommended except in cas-
es  of  possible  tumour  associated  symptoms  (weight
loss, haematuria, painful bones). only for intermediate
and  high-risk  patients  close  follow  up  by  Ct  scans
might be indicated. 
Besides the most likely location of recurrent dis-
ease, the average time until recurrence is decisive for
follow-up recommendations. according to the Mayo
scoring system [16] recurrence in the first year occurs
in patients with low-risk, intermediate-risk and high-
risk in 0.5, 9.6 and 42.3%, respectively. after 5 years
the recurrence rate raises up to 2.9, 26.2 and 68.8%,
respectively. as most recurrence occur within 5 years
after first diagnosis close follow-up might be omitted
after this time [24].
to the best of our knowledge there is no study in-
vestigating the follow-up modalities of patients with
renal cell carcinoma in Germany. neither it is known
if  patients  prefer  follow-up  examinations  by  their
urologist or general practitioner and how closely pa-
tients are followed up.
In our cohort, in 72% of patients were examined by
their urologist, followed by general practitioners (20%)
and nephrologists (9%). this distribution might be due
to the specific health system in Germany in which gen-
eral practitioners play the central role in referring on-
cologic patients to specialists (e. g. urologists). Many
patients  obviously  tend  to  undergo  follow-up  at  the
doctor  who  actually  diagnosed  the  tumor.  as  ultra-
sound  is  broadly  available  in  developed  countries  a
considerable  number  of  tumors  are  detected  during
routine check-up examinations by general practitioners. 
the types of technical examinations were the same
for patients after oRn and nss. In 96% ultrasound
was used, laboratory controls of urine and blood were
used  in  more  than  80%.  Ct  scans  of  abdomen 
and chest were used in 64% respectively 29% of pa-
tients. this is in line with most follow-up recommen-
dations  suggesting  Ct  scans  every  6  months  for  2
years  for  intermediate-  and  high-risk  patients.  Ct
scans of head (5%) or abdominal MRI (9%) were lim-
ited to selected cases or indications as suggested by
the Eau.
Interestingly  there  were  significant  differences  in
the examination modalities employed between urolo-
gists  and  non-urologist  health  professionals.  urolo-
gists applied all of them more often with the largest
discrepancy for imaging modalities. this might be an
indication that urologist more often stick to guideline
recommendations by urological associations.
nearly two thirds of patients were followed every
three months, which seems to be a reasonable interval
[7]. on the other hand up to 9% of patients were not
under surveillance at all, indicating the need of a bet-
ter patient education. 
only a small proportion of patients (13 – 18%) was
asking  for  psycho-oncological  support.  It  is  known
from larger studies that up to 41% of patients with tu-
mor disease are in need of professional psycho-onco-
logical support [25]. the discrepancy might be due to
a low tumor stage (most of them t1) in our patients
contributing to better well being compared to other
studies. as many patients might benefit of psycho-on-
cological support, it should be routinely and actively
offered during hospital stay. 
5. ConClusIons
Patients in our cohort appeared to be well followed-
up  according  to  existing  guidelines.  In  this  cohort
with low tumor stages only the minority of patients
asked for psycho-oncological support. 
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Fig. 5. Patients calling upon psycho-onco-
logical support.
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